Dr Oscar Duke, speaking on BBC Morning Live, has detailed a groundbreaking new treatment for lupus that could effectively 'reset' the immune system, offering hope to tens of thousands of people in the UK affected by this debilitating condition. Lupus, or systemic lupus erythematosus, is a chronic autoimmune disease where the immune system mistakenly attacks healthy tissues and organs, causing a wide range of symptoms that vary dramatically from person to person. Currently, there is no cure, but CAR T-cell therapy has shown promise in putting the disease into remission.
What Is Lupus and How Is It Currently Treated?
Lupus symptoms can include joint and muscle pain, extreme tiredness, facial rashes triggered by sunlight, headaches, mouth ulcers, high temperatures, hair loss, weight loss, swollen glands, depression, anxiety, chest or stomach pain, and changes in finger or toe color in cold or stress. Symptoms often come and go in flare-ups and periods of remission, though some patients experience constant symptoms. Current treatments involve suppressing the immune system to prevent it from attacking healthy tissues, but this leaves patients vulnerable to infections.
How CAR T-Cell Therapy Works
Dr Oscar described CAR T-cell therapy as a 'control, alt, delete' for the immune system. The treatment involves removing T cells from the patient's blood, modifying them so that upon reintroduction, they target and destroy B cells—the cells responsible for triggering autoimmune attacks in lupus. 'In your blood, you've got the white blood cells that fight infections, but they're also the ones that are attacking you in an autoimmune condition,' Dr Oscar explained. 'It tends to be the B cells that are the trigger of these sorts of autoimmune problems.'
Potential Benefits and Drawbacks
While the therapy eliminates the harmful B cells, it also destroys healthy B cells, temporarily increasing the risk of infections. 'So for a period of time until that all regrows and resets, you're also going to be at a higher risk of other infections that might have protected you from,' Dr Oscar warned. However, three years after treatment, some lupus patients have shown no signs of the disease, suggesting the therapy may induce long-term remission.
Future Implications
Dr Oscar noted that if CAR T-cell therapy proves effective for lupus, it could potentially be applied to other autoimmune conditions such as rheumatoid arthritis. This breakthrough offers new hope for patients who have limited treatment options, though further research is needed to confirm its safety and efficacy.
